Xie F - Search Results

1

A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L.

Hay JW, Gong CL, Jiao X, Zawadzki NK, Zawadzki RS, Pickard AS, Xie F, Crawford SA, Gu NY. Hay JW, et al. Among authors: xie f. J Gen Intern Med. 2021 May;36(5):1292-1301. doi: 10.1007/s11606-021-06674-z. Epub 2021 Mar 8. J Gen Intern Med. 2021. PMID: 33686587 Free PMC article.

2

Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?

Xie F, Pullenayegum E, Gaebel K, Oppe M, Krabbe PF. Xie F, et al. Eur J Health Econ. 2014 Apr;15(3):281-8. doi: 10.1007/s10198-013-0474-3. Epub 2013 Apr 4. Eur J Health Econ. 2014. PMID: 23553075

3

Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values.

Krabbe PF, Devlin NJ, Stolk EA, Shah KK, Oppe M, van Hout B, Quik EH, Pickard AS, Xie F. Krabbe PF, et al. Among authors: xie f. Med Care. 2014 Nov;52(11):935-43. doi: 10.1097/MLR.0000000000000178. Med Care. 2014. PMID: 25100229 Free PMC article.

4

Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

Pullenayegum EM, Perampaladas K, Gaebel K, Doble B, Xie F. Pullenayegum EM, et al. Among authors: xie f. Eur J Health Econ. 2015 Nov;16(8):847-55. doi: 10.1007/s10198-014-0633-1. Epub 2014 Sep 25. Eur J Health Econ. 2015. PMID: 25252970 Review.

5

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE).

Xie F, Pickard AS, Krabbe PF, Revicki D, Viney R, Devlin N, Feeny D. Xie F, et al. Pharmacoeconomics. 2015 Aug;33(8):867-77. doi: 10.1007/s40273-015-0292-9. Pharmacoeconomics. 2015. PMID: 26026667 Free PMC article.

6

Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.

Pullenayegum EM, Chan KK, Xie F. Pullenayegum EM, et al. Among authors: xie f. Med Decis Making. 2016 Feb;36(2):223-33. doi: 10.1177/0272989X15591966. Epub 2015 Jul 2. Med Decis Making. 2016. PMID: 26139449

7

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.

Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA; Canadian EQ-5D-5L Valuation Study Group. Xie F, et al. Med Care. 2016 Jan;54(1):98-105. doi: 10.1097/MLR.0000000000000447. Med Care. 2016. PMID: 26492214 Free PMC article.

8

Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.

Sayah FA, Bansback N, Bryan S, Ohinmaa A, Poissant L, Pullenayegum E, Xie F, Johnson JA. Sayah FA, et al. Among authors: xie f. Qual Life Res. 2016 Jul;25(7):1679-85. doi: 10.1007/s11136-015-1203-4. Epub 2015 Dec 10. Qual Life Res. 2016. PMID: 26659899

9

How different are composite and traditional TTO valuations of severe EQ-5D-5L states?

Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA. Xie F, et al. Qual Life Res. 2016 Aug;25(8):2101-8. doi: 10.1007/s11136-016-1242-5. Epub 2016 Feb 13. Qual Life Res. 2016. PMID: 26875190

10

EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada.

Tsiplova K, Pullenayegum E, Cooke T, Xie F. Tsiplova K, et al. Among authors: xie f. Qual Life Res. 2016 Dec;25(12):3009-3016. doi: 10.1007/s11136-016-1336-0. Epub 2016 Jun 15. Qual Life Res. 2016. PMID: 27307010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,122 results

Search Page